Safety And Efficacy Of UK-432,097 In Chronic Obstructive Pulmonary Disease.

NCT00430300 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

87

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG: UK-432,097
DRUG: Placebo

Sponsor

Pfizer